I am a
Home I AM A Search Login

Papers of the Week

Papers: 7 Sep 2019 - 13 Sep 2019

Animal Studies, Pharmacology/Drug Development


J Pain Res


Melatonin MT2 receptor agonist IIK-7 produces antinociception by modulation of ROS and suppression of spinal microglial activation in neuropathic pain rats.


Kuthati Y, Goutham Davuluri V N, Yang C-P, Chang H-C, Chang C-P, Wong C S
J Pain Res. 2019; 12:2473-2485.
PMID: 31496789.


In recent years, several melatonin (MLT) receptor agonists have been approved by FDA for the treatment of sleep disorders and depression. Very few studies have shed light on their efficacy against neuropathic pain (NP). IIK-7 is an MT-2 agonist known to promote sleep. Whether IIK-7 suppresses NP has not been reported, and the signaling profile is unknown.